Conference
Recurrent disease in patients with stage III melanoma in the era of adjuvant immune and targeted therapy.
Abstract
e21570
Authors
Lo V; Francescutti V; McWhirter E; Farrokhyar F; Lee LM
Volume
39
Pagination
pp. e21570-e21570
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2021
DOI
10.1200/jco.2021.39.15_suppl.e21570
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X